SPRO
Spero Therapeutics, Inc.
Company overview
- Market capitalization
- $69.30M
- Employees
- 25
- Latest publication
- 2026-09-29
About Spero Therapeutics, Inc.
Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying and developing novel treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include Tebipenem HBr (tebipenem pivoxil hydrobromide), an oral carbapenem-class antibiotic to treat complicated urinary tract infections, including pyelonephritis for adult patients, which has completed second Phase 3 trial. It has license agreement with Meiji Seika Pharma Co., Ltd. to develop, manufacture, and commercialize tebipenem pivoxil and tebipenem HBr; and Everest Medicines to develop, manufacture, and commercialize SPR206 in Greater China, South Korea, and Southeast Asian countries. Spero Therapeutics, Inc. was incorporated in 2013 and is headquartered in Cambridge, Massachusetts.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 258,000USD | 39,658,000USD | 3,048,000USD | 11,802,000USD | 5,874,000USD | 15,044,000USD | 13,469,000USD |
| Research Development | 3,434,000USD | 2,909,000USD | 5,592,000USD | 8,597,000USD | 10,672,000USD | 13,606,000USD | 28,836,000USD | 26,864,000USD |
| Selling General Administrative | 6,492,000USD | 4,887,000USD | 4,300,000USD | 4,174,000USD | 5,878,000USD | 6,824,000USD | 6,264,000USD | 5,198,000USD |
| General And Administrative Expenses | 6,492,000USD | — | — | — | — | — | — | — |
| Total Operating Expenses | 9,926,000USD | 7,796,000USD | 8,253,000USD | 10,964,000USD | 14,246,000USD | 6,999,000USD | -57,865,000USD | 32,062,000USD |
| Operating Income | -9,926,000USD | -7,538,000USD | 31,405,000USD | -7,916,000USD | -2,444,000USD | -14,731,000USD | -21,725,000USD | -18,593,000USD |
| Total Other Income Expense Net | 374,000USD | 335,000USD | 376,000USD | 534,000USD | 744,000USD | 865,000USD | 1,127,000USD | 1,156,000USD |
| Interest Income | 377,000USD | 336,000USD | 376,000USD | 532,000USD | 740,000USD | 864,000USD | 1,028,000USD | 1,182,000USD |
| Net Income | -9,552,000USD | -7,203,000USD | 31,520,000USD | -7,382,000USD | -1,700,000USD | -13,866,000USD | -20,888,000USD | -17,147,000USD |
| Gross Profit | — | 258,000USD | 39,658,000USD | 3,048,000USD | 11,802,000USD | -7,732,000USD | -79,590,000USD | 13,469,000USD |
| Net Interest Income | — | 336,000USD | 376,000USD | 532,000USD | 740,000USD | 864,000USD | 1,028,000USD | 1,182,000USD |
| Income Before Tax | — | -7,203,000USD | 31,781,000USD | -7,382,000USD | -1,700,000USD | -13,866,000USD | -20,598,000USD | -17,437,000USD |
| Net Income From Continuing Ops | — | -7,203,000USD | 31,520,000USD | -7,382,000USD | -1,700,000USD | -13,866,000USD | -20,888,000USD | -17,147,000USD |
| Ebitda | — | -7,538,000USD | 31,405,000USD | -7,382,000USD | -2,361,000USD | -14,555,500USD | -20,848,000USD | -18,591,000USD |
| Unclassified Operating Expenses | — | — | -1,639,000USD | -1,807,000USD | -2,304,000USD | -13,431,000USD | -92,965,000USD | — |
| Income Tax Expense | — | — | 261,000USD | — | — | — | 290,000USD | -290,000USD |
| Tax Provision | — | — | 261,000USD | 0USD | — | — | 290,000USD | -290,000USD |
| Reconciled Depreciation | — | — | 0USD | 0USD | — | — | 0USD | 0USD |
| Cost Of Revenue | — | — | — | — | — | 13,606,000USD | 94,634,000USD | 2,000USD |
| Ebit | — | — | — | — | — | -14,556,000USD | -20,754,250USD | -18,593,000USD |
| Depreciation And Amortization | — | — | — | — | — | 500USD | -93,750USD | 2,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 59,619,000USD | 47,977,000USD | 103,781,000USD | 48,579,000USD | 3,070,000USD | 9,330,000USD | 4,742,000USD | 3,966,000USD |
| Gross Profit | 59,619,000USD | -48,780,000USD | 52,341,000USD | 48,579,000USD | 3,070,000USD | 9,330,000USD | 4,742,000USD | 3,966,000USD |
| Research Development | 38,467,000USD | 96,757,000USD | 51,440,000USD | 47,593,000USD | 64,526,000USD | 67,003,000USD | 65,775,000USD | 33,885,000USD |
| Selling General Administrative | 21,176,000USD | 22,912,000USD | 24,988,000USD | 36,483,000USD | 41,701,000USD | 21,440,000USD | 15,588,000USD | 12,887,000USD |
| Total Operating Expenses | 59,643,000USD | 24,581,000USD | 30,860,000USD | 90,776,000USD | 91,041,000USD | 88,443,000USD | 67,958,000USD | 42,806,000USD |
| Operating Income | -24,000USD | -73,361,000USD | 21,481,000USD | -42,197,000USD | -87,971,000USD | -79,113,000USD | -63,216,000USD | -42,806,000USD |
| Interest Income | 2,512,000USD | 4,735,000USD | 3,937,000USD | 1,106,000USD | 346,000USD | 401,000USD | 1,328,000USD | 1,144,000USD |
| Net Interest Income | 2,512,000USD | 4,735,000USD | 3,937,000USD | -1,499,000USD | -1,594,000USD | 401,000USD | 1,328,000USD | 1,144,000USD |
| Income Before Tax | 8,833,000USD | -68,566,000USD | 25,404,000USD | -46,415,000USD | -89,756,000USD | -78,280,000USD | -60,925,000USD | -41,662,000USD |
| Income Tax Expense | 261,000USD | — | 2,598,000USD | 1,613,000USD | 1,545,000USD | -761,000USD | -750,000USD | 1,144,000USD |
| Tax Provision | 261,000USD | 0USD | 2,598,000USD | 0USD | — | — | — | — |
| Net Income | 8,572,000USD | -68,566,000USD | 22,806,000USD | -46,415,000USD | -89,756,000USD | -77,519,000USD | -60,175,000USD | -41,662,000USD |
| Net Income From Continuing Ops | 8,572,000USD | -68,566,000USD | 22,806,000USD | -46,415,000USD | -89,756,000USD | -78,280,000USD | -60,925,000USD | -41,662,000USD |
| Ebitda | -24,000USD | -72,482,000USD | 27,154,000USD | -42,941,000USD | -87,170,000USD | -78,352,000USD | -62,466,000USD | -42,397,000USD |
| Reconciled Depreciation | 0USD | 2,000USD | 367,000USD | 869,000USD | 646,000USD | 761,000USD | 750,000USD | 409,000USD |
| Total Other Income Expense Net | 8,857,000USD | 4,795,000USD | 3,923,000USD | -4,218,000USD | -1,785,000USD | 833,000USD | 2,291,000USD | 1,144,000USD |
| Cost Of Revenue | — | 96,757,000USD | 51,440,000USD | 1,547,000USD | 1,117,000USD | 67,003,000USD | 65,775,000USD | 33,885,000USD |
| Unclassified Operating Expenses | — | -95,088,000USD | -45,568,000USD | 6,700,000USD | -15,186,000USD | — | -13,405,000USD | -3,966,000USD |
| Ebit | — | -72,484,000USD | 26,787,000USD | -43,810,000USD | -87,816,000USD | -79,113,000USD | -63,216,000USD | -42,806,000USD |
| Depreciation And Amortization | — | 2,000USD | 367,000USD | 869,000USD | 646,000USD | 761,000USD | 750,000USD | 409,000USD |
| Interest Expense | — | — | 0USD | 2,605,000USD | 1,940,000USD | 0USD | 0USD | 303,000USD |
| Net Income Applicable To Common Shares | — | — | — | -46,415,000USD | -89,756,000USD | -78,280,000USD | -60,925,000USD | -41,662,000USD |
| Selling And Marketing Expenses | — | — | — | — | — | 476,000USD | — | — |
| Non Operating Income Net Other | — | — | — | — | — | 833,000USD | 2,291,000USD | 1,144,000USD |
| Minority Interest | — | — | — | — | — | — | — | 355,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 52,766,000USD | 59,021,000USD | 68,919,000USD | 54,170,000USD | 62,119,000USD | 77,709,000USD | 110,543,000USD | 135,161,000USD |
| Cash And Equivalents | 50,774,000USD | — | — | — | — | — | — | — |
| Total Current Assets | 51,584,000USD | 57,612,000USD | 67,286,000USD | 52,323,000USD | 59,402,000USD | 74,714,000USD | 107,276,000USD | 131,627,000USD |
| Other Current Assets | 25,000USD | 1,439,000USD | 1,634,000USD | 1,248,000USD | 3,755,000USD | 1,548,000USD | 1,911,000USD | 2,055,000USD |
| Other Non Current Assets | 153,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 8,562,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 8,428,000USD | 5,489,000USD | 8,868,000USD | 13,649,000USD | 14,945,000USD | 29,155,000USD | 49,074,000USD | 49,096,000USD |
| Total Stockholder Equity | 44,204,000USD | 52,934,000USD | 59,021,000USD | 26,494,000USD | 32,828,000USD | 33,814,000USD | 46,123,000USD | 65,507,000USD |
| Total Equity Including Noncontrolling Interest | 44,204,000USD | — | — | — | — | — | — | — |
| Property Plant Equipment Net | 1,029,000USD | 1,256,000USD | 1,480,000USD | 1,694,000USD | 2,564,000USD | 2,842,000USD | 3,114,000USD | 3,381,000USD |
| Accounts Payable | 155,000USD | 217,000USD | 693,000USD | 1,395,000USD | 780,000USD | 1,765,000USD | 7,306,000USD | 6,090,000USD |
| Short Term Debt | 2,000,000USD | 1,967,000USD | 1,956,000USD | 1,899,000USD | 1,844,000USD | 1,795,000USD | 1,746,000USD | 1,739,000USD |
| Common Stock | 58,000USD | 58,000USD | 56,000USD | 56,000USD | 56,000USD | 56,000USD | 55,000USD | 54,000USD |
| Retained Earnings | -467,821,000USD | -458,269,000USD | -451,066,000USD | -482,586,000USD | -475,204,000USD | -473,504,000USD | -459,638,000USD | -438,750,000USD |
| Total Liab | — | 6,087,000USD | 9,898,000USD | 27,676,000USD | 29,291,000USD | 43,895,000USD | 64,420,000USD | 69,654,000USD |
| Other Current Liab | — | 3,142,000USD | 5,578,000USD | 7,809,000USD | 12,321,000USD | 8,362,000USD | 17,724,000USD | 15,328,000USD |
| Capital Stock | — | 58,000USD | 56,000USD | 56,000USD | 56,000USD | 56,000USD | 55,000USD | 54,000USD |
| Cash | — | 56,129,000USD | 40,265,000USD | 48,616,000USD | 31,194,000USD | 48,887,000USD | 52,889,000USD | 76,290,000USD |
| Cash And Short Term Investments | — | 56,129,000USD | 40,265,000USD | 48,616,000USD | 31,194,000USD | 48,887,000USD | 52,889,000USD | 76,290,000USD |
| Net Debt | — | -53,655,000USD | -37,370,000USD | -45,265,000USD | -27,579,000USD | -44,927,000USD | -48,592,000USD | -71,668,000USD |
| Short Long Term Debt Total | — | 2,474,000USD | 2,895,000USD | 3,351,000USD | 3,615,000USD | 3,960,000USD | 4,297,000USD | 4,622,000USD |
| Net Receivables | — | 44,000USD | 25,387,000USD | 2,459,000USD | 24,453,000USD | 24,279,000USD | 52,476,000USD | 53,282,000USD |
| Property Plant Equipment Gross | — | 1,256,000USD | 1,480,000USD | 1,694,000USD | 2,564,000USD | 2,842,000USD | 6,734,000USD | 3,381,000USD |
| Common Stock Shares Outstanding | — | 57,281,570shares | 59,368,159shares | 56,280,844shares | 56,026,767shares | 55,376,188shares | 54,037,917shares | 54,124,862shares |
| Non Current Assets Total | — | 1,409,000USD | 1,633,000USD | 1,847,000USD | 2,717,000USD | 2,995,000USD | 3,267,000USD | 3,534,000USD |
| Non Current Liabilities Total | — | 598,000USD | 1,030,000USD | 14,027,000USD | 14,346,000USD | 14,740,000USD | 15,346,000USD | 20,558,000USD |
| Non Current Liabilities Other | — | 91,000USD | 91,000USD | — | — | — | — | 13,000USD |
| Non Currrent Assets Other | — | 153,000USD | 153,000USD | 153,000USD | 153,000USD | 153,000USD | 153,000USD | 153,000USD |
| Net Working Capital | — | 52,123,000USD | 58,418,000USD | 38,674,000USD | 44,457,000USD | 45,559,000USD | 58,202,000USD | 82,531,000USD |
| Unclassified Equity | — | 511,087,000USD | 509,975,000USD | 508,968,000USD | 507,920,000USD | 507,206,000USD | 505,651,000USD | 504,149,000USD |
| Current Deferred Revenue | — | — | 258,000USD | 2,383,000USD | 5,431,000USD | 17,233,000USD | 22,124,000USD | 25,842,000USD |
| Unclassified Non Current Liabilities | — | — | — | 14,027,000USD | 14,346,000USD | 14,740,000USD | 15,346,000USD | 20,545,000USD |
| Unclassified Current Liabilities | — | — | — | — | -5,431,000USD | — | — | — |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 68,919,000USD | 110,543,000USD | 182,390,000USD | 124,802,000USD | 171,072,000USD | 153,451,000USD | 106,103,000USD | 129,006,000USD |
| Other Current Assets | 1,634,000USD | 1,911,000USD | 4,178,000USD | 3,379,000USD | 8,829,000USD | 12,239,000USD | 3,123,000USD | 14,956,000USD |
| Total Liab | 9,898,000USD | 64,420,000USD | 75,496,000USD | 48,868,000USD | 82,783,000USD | 21,411,001USD | 31,529,000USD | 13,151,000USD |
| Total Stockholder Equity | 59,021,000USD | 46,123,000USD | 106,894,000USD | 75,934,000USD | 88,289,000USD | 132,039,999USD | 74,574,000USD | 115,855,000USD |
| Other Current Liab | 5,578,000USD | 17,724,000USD | 6,557,000USD | 8,973,000USD | 14,350,000USD | 12,241,000USD | 21,588,000USD | 8,715,000USD |
| Common Stock | 56,000USD | 55,000USD | 53,000USD | 52,000USD | 32,000USD | 29,000USD | 19,000USD | 17,000USD |
| Capital Stock | 56,000USD | 55,000USD | 53,000USD | 52,000USD | 35,000USD | 32,000USD | 19,000USD | 17,000USD |
| Retained Earnings | -451,066,000USD | -459,638,000USD | -391,072,000USD | -413,878,000USD | -367,463,000USD | -277,707,000USD | -199,427,000USD | -138,502,000USD |
| Cash | 40,265,000USD | 52,889,000USD | 76,333,000USD | 109,107,000USD | 112,584,000USD | 85,209,000USD | 29,730,000USD | 34,080,000USD |
| Cash And Short Term Investments | 40,265,000USD | 52,889,000USD | 76,333,000USD | 109,107,000USD | 146,402,000USD | 126,906,000USD | 82,045,000USD | 115,443,000USD |
| Total Current Assets | 67,286,000USD | 107,276,000USD | 131,208,000USD | 109,107,000USD | 157,872,000USD | 139,145,000USD | 95,414,000USD | 115,443,000USD |
| Total Current Liabilities | 8,868,000USD | 49,074,000USD | 37,153,000USD | 21,649,000USD | 18,670,000USD | 14,343,000USD | 26,663,000USD | 12,318,000USD |
| Current Deferred Revenue | 258,000USD | 22,124,000USD | 27,113,000USD | 10,369,000USD | 1,857,000USD | — | — | — |
| Net Debt | -37,370,000USD | -48,592,000USD | -70,790,000USD | -102,460,000USD | -105,249,000USD | -77,371,000USD | -24,185,000USD | -34,080,000USD |
| Short Term Debt | 1,956,000USD | 1,746,000USD | 1,718,000USD | 1,690,000USD | 1,362,000USD | 947,000USD | 928,000USD | 223,000USD |
| Short Long Term Debt Total | 2,895,000USD | 4,297,000USD | 5,543,000USD | 6,647,000USD | 7,335,000USD | 7,838,000USD | 5,545,000USD | — |
| Net Receivables | 25,387,000USD | 52,476,000USD | 50,697,000USD | 1,084,000USD | 2,641,000USD | 6,176,000USD | 10,246,000USD | 1,298,000USD |
| Accounts Payable | 693,000USD | 7,306,000USD | 1,378,000USD | 617,000USD | 1,101,000USD | 1,155,000USD | 4,147,000USD | 3,603,000USD |
| Property Plant Equipment Net | 1,480,000USD | 3,114,000USD | 4,157,000USD | 5,492,000USD | 7,556,000USD | 8,783,000USD | 7,148,000USD | 2,893,000USD |
| Property Plant Equipment Gross | 1,480,000USD | 6,734,000USD | 7,775,000USD | 8,744,000USD | 10,436,000USD | 8,783,000USD | 7,148,000USD | 2,893,000USD |
| Common Stock Shares Outstanding | 59,039,225shares | 54,037,917shares | 52,989,030shares | 37,585,075shares | 30,895,756shares | 22,386,122shares | 18,160,525shares | 16,001,832shares |
| Non Current Assets Total | 1,633,000USD | 3,267,000USD | 51,181,999USD | 15,695,000USD | 13,200,000USD | 14,306,000USD | 10,688,999USD | 13,563,000USD |
| Non Current Liabilities Total | 1,030,000USD | 15,346,000USD | 38,343,000USD | 27,219,000USD | 64,113,000USD | 7,068,001USD | 4,866,000USD | 833,000USD |
| Non Current Liabilities Other | 91,000USD | — | 87,000USD | 96,000USD | 48,552,000USD | 6,891,000USD | 249,000USD | — |
| Non Currrent Assets Other | 153,000USD | 153,000USD | 434,999USD | 10,203,000USD | 5,644,000USD | 5,523,000USD | 3,519,999USD | 10,437,000USD |
| Net Working Capital | 58,418,000USD | 58,202,000USD | 94,055,000USD | 91,921,000USD | 139,202,000USD | 124,802,000USD | 68,751,000USD | 111,901,000USD |
| Unclassified Equity | 509,975,000USD | 505,651,000USD | 497,860,000USD | 489,708,000USD | 455,687,000USD | 409,692,999USD | 273,947,000USD | 254,351,000USD |
| Unclassified Non Current Liabilities | — | 15,346,000USD | 38,256,000USD | 4,861,000USD | -42,579,000USD | — | 4,119,000USD | — |
| Other Assets | — | — | 1USD | 5,740,000USD | 5,644,000USD | 5,523,000USD | 3,541,000USD | 1,894,000USD |
| Inventory | — | — | 1USD | -4,463,000USD | -361,000USD | -12,239,000USD | -13,369,000USD | -8,776,000USD |
| Unclassified Non Current Assets | — | — | 46,589,999USD | -5,740,000USD | -5,644,000USD | -5,523,000USD | -3,520,000USD | -1,661,000USD |
| Other Liab | — | — | — | 22,262,000USD | 58,140,000USD | 177,000USD | 249,000USD | 833,000USD |
| Short Term Investments | — | — | — | 0USD | 33,818,000USD | 41,697,000USD | 52,315,000USD | 81,363,000USD |
| Net Tangible Assets | — | — | — | 75,934,000USD | 88,286,000USD | 132,037,000USD | 74,574,000USD | 115,500,000USD |
| Unclassified Current Assets | — | — | — | -4,463,000USD | — | -6,176,000USD | — | -16,254,000USD |
| Accumulated Other Comprehensive Income | — | — | — | — | -2,000USD | -7,000USD | 16,000USD | -28,000USD |
| Long Term Debt | — | — | — | — | — | 177,000USD | 249,000USD | — |
| Deferred Long Term Liab | — | — | — | — | — | — | — | 316,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Stock Based Compensation | 1,936,000USD |
| Change To Liabilities | -6,000USD |
| Change In Working Capital | 91,000USD |
| Operating Cash Flow | 10,509,000USD |
| Change In Cash | 10,509,000USD |
| End Cash Flow | 50,774,000USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -7,203,000USD | 31,520,000USD | -7,382,000USD | -1,700,000USD | -13,866,000USD | -20,888,000USD | -17,147,000USD | -17,862,000USD |
| Stock Based Compensation | 1,114,000USD | 1,007,000USD | 1,048,000USD | 714,000USD | 1,556,000USD | 1,503,000USD | 2,154,000USD | 2,113,000USD |
| Other Non Cash Items | 1,340,000USD | 214,000USD | 870,000USD | 278,000USD | 273,000USD | 268,000USD | 263,000USD | 258,000USD |
| Change To Account Receivables | 25,343,000USD | 1,563,000USD | 869,000USD | -1,792,000USD | 2,417,000USD | -389,000USD | 2,038,000USD | 283,000USD |
| Change In Working Capital | 21,727,000USD | -41,092,000USD | 22,886,000USD | -16,985,000USD | 8,035,000USD | -4,284,000USD | 27,493,000USD | -3,255,000USD |
| Total Cash From Operating Activities | 15,864,000USD | -8,351,000USD | 17,422,000USD | -17,693,000USD | -4,002,000USD | -23,401,000USD | 12,763,000USD | -18,744,000USD |
| Capital Expenditures | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Free Cash Flow | 15,864,000USD | -8,351,000USD | 17,422,000USD | -17,693,000USD | -4,002,000USD | -23,401,000USD | 12,763,000USD | -18,744,000USD |
| Change In Cash | 15,864,000USD | -8,351,000USD | 17,422,000USD | -17,693,000USD | -4,002,000USD | -23,401,000USD | 12,763,000USD | -18,744,000USD |
| Begin Period Cash Flow | 40,265,000USD | 48,616,000USD | 31,194,000USD | 48,887,000USD | 52,889,000USD | 76,290,000USD | 63,527,000USD | 82,271,000USD |
| End Period Cash Flow | 56,129,000USD | 40,265,000USD | 48,616,000USD | 31,194,000USD | 48,887,000USD | 52,889,000USD | 76,290,000USD | 63,527,000USD |
| Unclassified Operating Cash Flow | -1,114,000USD | — | — | — | — | — | — | — |
| Depreciation | — | 0USD | 0USD | — | — | 0USD | 0USD | 2,000USD |
| Total Cash From Financing Activities | — | — | — | — | — | 0USD | — | — |
| Issuance Of Capital Stock | — | — | — | — | — | 0USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | 8,572,000USD | -68,566,000USD | 22,806,000USD | -46,415,000USD | -89,756,000USD | -78,280,000USD | -60,925,000USD | -41,662,000USD |
| Depreciation | 0USD | 2,000USD | 367,000USD | 1,547,000USD | 1,117,000USD | 761,000USD | 750,000USD | 409,000USD |
| Stock Based Compensation | 4,325,000USD | 7,793,000USD | 7,932,000USD | 9,123,000USD | 9,430,000USD | 4,888,000USD | 3,776,000USD | 2,749,000USD |
| Other Non Cash Items | 1,635,000USD | 1,043,000USD | 6,275,000USD | 15,050,000USD | 11,430,000USD | 151,000USD | 356,000USD | -50,000USD |
| Change To Account Receivables | 3,057,000USD | -1,540,000USD | -461,000USD | 1,547,000USD | 3,832,000USD | 2,176,000USD | -7,085,000USD | 1,405,000USD |
| Change In Working Capital | -27,156,000USD | 36,284,000USD | -70,375,000USD | 22,087,000USD | 12,862,000USD | -13,392,000USD | 6,831,000USD | -1,071,000USD |
| Total Cash From Operating Activities | -12,624,000USD | -23,444,000USD | -32,995,000USD | -7,731,000USD | -64,346,999USD | -85,872,000USD | -50,020,000USD | -39,625,000USD |
| Capital Expenditures | 0USD | 0USD | 0USD | 0USD | -64,346,999USD | -157,000USD | -314,000USD | -2,436,000USD |
| Free Cash Flow | -12,624,000USD | -23,444,000USD | -32,995,000USD | -7,731,000USD | -64,308,000USD | -86,029,000USD | -50,334,000USD | -42,061,000USD |
| Change In Cash | -12,624,000USD | -23,444,000USD | -32,774,000USD | -3,477,000USD | 27,375,000USD | 55,479,000USD | -4,350,000USD | -53,258,000USD |
| Begin Period Cash Flow | 52,889,000USD | 76,333,000USD | 109,107,000USD | 112,584,000USD | 85,209,000USD | 29,730,000USD | 34,080,000USD | 87,338,000USD |
| End Period Cash Flow | 40,265,000USD | 52,889,000USD | 76,333,000USD | 109,107,000USD | 112,584,000USD | 85,209,000USD | 29,730,000USD | 34,080,000USD |
| Total Cash From Financing Activities | — | 0USD | 221,000USD | -29,553,000USD | 84,050,000USD | 130,881,000USD | 16,140,000USD | 69,523,000USD |
| Issuance Of Capital Stock | — | 0USD | 221,000USD | 24,512,000USD | 35,368,000USD | 129,645,000USD | 15,790,000USD | 70,500,000USD |
| Investments | — | — | 0USD | 33,807,000USD | 7,672,000USD | 10,627,000USD | 29,844,000USD | -80,720,000USD |
| Other Cashflows From Financing Activities | — | — | 221,000USD | 420,000USD | 1,202,000USD | 52,221,000USD | 350,000USD | -977,000USD |
| Change To Inventory | — | — | — | -1,547,000USD | -3,832,000USD | -2,176,000USD | 7,085,000USD | — |
| Change To Liabilities | — | — | — | 21,408,000USD | 10,590,000USD | -12,177,000USD | 14,122,000USD | 3,659,000USD |
| Total Cashflows From Investing Activities | — | — | — | 33,807,000USD | 7,672,000USD | 10,470,000USD | 29,530,000USD | -83,156,000USD |
| Net Borrowings | — | — | — | -54,485,000USD | -54,485,000USD | -54,485,000USD | -54,485,000USD | — |
| Dividends Paid | — | — | — | -54,485,000USD | -47,480,000USD | — | — | — |
| Sale Purchase Of Stock | — | — | — | 10,278,000USD | 27,537,000USD | 14,180,000USD | 16,140,000USD | 69,523,000USD |
| Other Cashflows From Investing Activities | — | — | — | 33,807,000USD | 39,000USD | 10,627,000USD | 29,844,000USD | -83,156,000USD |
| Unclassified Operating Cash Flow | — | — | — | -9,123,000USD | -9,429,999USD | — | — | — |
| Unclassified Investing Cash Flow | — | — | — | -33,807,000USD | 64,307,999USD | -10,627,000USD | -29,844,000USD | 83,156,000USD |
| Unclassified Financing Cash Flow | — | — | — | 68,719,000USD | 157,276,000USD | 118,965,000USD | 54,135,000USD | — |
| Cash And Cash Equivalents Changes | — | — | — | — | — | 55,479,000USD | -4,350,000USD | -53,258,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q1 2026Quarterly · 2026-03-31 | Product | Collaboration Revenue | 0 | USD | 0001193125-26-221591 |
| Q1 2026Quarterly · 2026-03-31 | Product | Collaboration Revenue Related Party | 258,000 | USD | 0001193125-26-221591 |
| Q1 2026Quarterly · 2026-03-31 | Product | Grant | 0 | USD | 0001193125-26-221591 |
| Q1 2026Quarterly · 2026-03-31 | Product | Grant Revenue | 0 | USD | 0001193125-26-221591 |
| Q3 2022Quarterly · 2022-09-30 | Product | Grant | 600,000 | USD | 0000950170-23-062897 |
| Q3 2022Quarterly · 2022-09-30 | Product | Other | 182,000 | USD | 0000950170-23-062897 |
| Q3 2022Quarterly · 2022-09-30 | Product | SPRTwo Zero Six | 300,000 | USD | 0000950170-23-062897 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.